Esophageal Squamous Cell Carcinoma
📧 Sign up to get email alerts when something new happens for Esophageal Squamous Cell Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2022-03-15Clinical Trial Update: Neoadjuvant Chemotherapy With Nab-paclitaxel Plus Cisplatin and Capecitabine for Locally Advanced Thoracic Esophageal Squamous Cell Carcinoma [Phase 2]
Phase 2 trial update on neoadjuvant chemotherapy with nab-paclitaxel, cisplatin, and capecitabine for locally advanced thoracic esophageal s…
-
CLINICAL_TRIALS trial_result · 2022-03-04Clinical Trial Update: Decitabine Plus Penpulimab as Second-line Therapy for Advanced ESCC Treated With PD-1 Blockade [Phase 2]
Phase 2 trial evaluating decitabine in combination with penpulimab as second-line therapy for advanced esophageal squamous cell carcinoma af…
-
CLINICAL_TRIALS trial_result · 2022-03-04Clinical Trial Update: The Phase II Trial of SHR-1210 Combined With Preoperative Chemotherapy or Apatinib for Locally Advanced ESCC [Phase 2]
Phase II trial evaluating SHR-1210 with preoperative chemotherapy or apatinib for locally advanced esophageal squamous cell carcinoma is in …
-
CLINICAL_TRIALS trial_result · 2022-02-09Clinical Trial Update: A Comparison of Paclitaxel-based Three Regimens Concurrent With Radiotherapy for Patients With Local Advanced Esophageal Cancer [Phase 3]
Phase 3 trial comparing paclitaxel-based regimens with radiotherapy in locally advanced esophageal squamous cell carcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2022-02-09Clinical Trial Update: Toripalimab With Neoadjuvant Chemotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma [Phase 2]
Phase 2 trial evaluating toripalimab in combination with neoadjuvant chemotherapy for locally advanced esophageal squamous cell carcinoma.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-12-30Clinical Trial Update: Effectiveness of Neoadjuvant Chemotherapy Combined With PD-1 Monoclonal Antibody in the Treatment of Operable Esophageal Squamous Cell Carcinoma [Phase 2]
Phase 2 trial evaluating neoadjuvant chemotherapy with a PD-1 monoclonal antibody for operable esophageal squamous cell carcinoma.
-
CLINICAL_TRIALS trial_result · 2021-12-28Clinical Trial Update: The Neoadjuvant Treatment of Locally Advanced Thoracic Esophageal Squamous Cell Carcinoma. [Phase 2]
Phase 2 trial update investigating neoadjuvant treatment for locally advanced thoracic esophageal squamous cell carcinoma using camrelizumab…
-
CLINICAL_TRIALS trial_result · 2021-12-21Clinical Trial Update: PD-1 Inhibitor Combined With Neoadjuvant Chemotherapy in Subjects With Resectable Locally Advanced Thoracic Esophageal Squamous Cell Carcinoma [Phase 2]
Phase 2 clinical trial exploring a PD-1 inhibitor combined with neoadjuvant chemotherapy in resectable locally advanced thoracic esophageal …
-
CLINICAL_TRIALS trial_result · 2021-12-14Clinical Trial Update: Camrelizumab in Combination With Neoadjuvant Chemotherapy for Resectable Thoracic Esophageal Squamous Cell Carcinoma [Phase 1, Phase 2]
A clinical trial update on camrelizumab combined with neoadjuvant chemotherapy for resectable thoracic esophageal squamous cell carcinoma sp…
-
CLINICAL_TRIALS trial_result · 2021-12-13Clinical Trial Update: The Study to Evaluate Toripalimab (JS001) in Patients With Advanced GC, ESCC, NPC, HNSCC [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating toripalimab (JS001) in advanced gastric cancer and multiple squamous cell carcinomas including esophagea…
-
CLINICAL_TRIALS trial_result · 2021-11-23Clinical Trial Update: Neo-NTP-CRT for Locally Advanced ESCC [Phase 2]
Phase 2 trial update for Neo-NTP-CRT in locally advanced esophageal squamous cell carcinoma.
-
CLINICAL_TRIALS trial_result · 2021-11-12Clinical Trial Update: Study Compare Adjuvant Chemotherapy, Chemoradiotherapy and Surgery Alone for pN1-2(pT1b-3N1-2M0) Esophageal Carcinoma [Phase 3]
A Phase 3 trial comparing adjuvant chemotherapy, chemoradiotherapy, and surgery alone for pN1-2 (pT1b-3N1-2M0) esophageal carcinoma is curre…
-
CLINICAL_TRIALS trial_result · 2021-11-08Clinical Trial Update: The Effect of Andrographis Paniculata (AP) on Palliative Management of Advanced Esophageal Cancer [Phase 3]
Phase 3 trial update evaluating Andrographis Paniculata for palliative management in advanced esophageal squamous cell carcinoma; study comp…
-
CLINICAL_TRIALS trial_result · 2021-11-02Clinical Trial Update: Salvage Immunotherapy and Chemotherapy in Esophageal Squamous Cell Carcinoma Patients Nonresponding to Initial Neoadjuvant Chemoradiotherapy [Phase 2]
Phase 2 clinical trial evaluating salvage immunotherapy and chemotherapy in esophageal squamous cell carcinoma patients who did not respond …
-
CLINICAL_TRIALS trial_result · 2021-09-20Clinical Trial Update: Study of Anti-PD-1 Antibody SHR-1210 Plus Apatinib vs SHR-1210 as Second-Line Treatment of Advanced Esophageal Squamous Cell [Phase 3]
Phase 3 trial evaluating SHR-1210 (PD-1 antibody) plus apatinib versus SHR-1210 alone as second-line treatment for advanced esophageal squam…
-
CLINICAL_TRIALS trial_result · 2021-09-16Clinical Trial Update: Exploration of Immunodynamic Monitoring in the Population Evaluation of Neoadjuvant Chemotherapy Immunotherapy in Patients With Solid Tumors of the Chest. [Phase 2]
Phase 2 clinical trial exploring immunodynamic monitoring during neoadjuvant chemotherapy immunotherapy in solid chest tumors, including non…
-
CLINICAL_TRIALS trial_result · 2021-09-08Clinical Trial Update: The Ave-CRT Study for Newly Diagnosed Metastatic Esophageal Squamous Cell Carcinoma [Phase 2]
Phase 2 clinical trial update for Ave-CRT in newly diagnosed metastatic esophageal squamous cell carcinoma.
-
CLINICAL_TRIALS trial_result · 2021-09-02Clinical Trial Update: Study of Anlotinib Plus Irinotecan in Patients With Esophageal Squamous Cell Carcinoma [Phase 2]
A Phase 2 study evaluating anlotinib in combination with irinotecan for esophageal squamous cell carcinoma is underway, with status not spec…
-
CLINICAL_TRIALS trial_result · 2021-08-25Clinical Trial Update: A Phase Ⅱ Trials of Sintilimab as Consolidation Therapy After Radical Concurrent Chemoradiotherapy in Locally Advanced Unresectable ESCC [Phase 2]
Phase 2 trial evaluating sintilimab as consolidation therapy after radical chemoradiotherapy in locally advanced unresectable esophageal squ…
-
CLINICAL_TRIALS trial_result · 2021-08-24Clinical Trial Update: Paclitaxel and DDP Combined With Anlotinib in the First-line Treatment for Patients With Advanced Esophageal Squamous Cell Carcinoma（ESCC）. [Phase 2]
Phase 2 trial evaluating paclitaxel and cisplatin (DDP) combined with anlotinib as first-line therapy for advanced esophageal squamous cell …
-
CLINICAL_TRIALS trial_result · 2021-08-23Clinical Trial Update: A Phase Ⅱ Clinical Trial of Camrelizumab for Adjuvant Treatment of Resectable Esophageal Squamous Cell Carcinoma [Phase 2]
A Phase 2 clinical trial assessing camrelizumab as adjuvant therapy for resectable esophageal squamous cell carcinoma.
-
CLINICAL_TRIALS trial_result · 2021-08-23Clinical Trial Update: Exploring the Safety and Effectiveness of Toripalimab Combined With Neoadjuvant Radiotherapy and Chemotherapy in the Locally Advanced Esophageal Squamous Cell Carcinoma [Phase 2]
Phase 2 clinical trial evaluating safety and effectiveness of toripalimab with neoadjuvant radiotherapy and chemotherapy for locally advance…
-
CLINICAL_TRIALS trial_result · 2021-07-30Clinical Trial Update: Chidamide Plus Camrelizumab as Second-line Therapy for Advanced ESCC Treated With PD-1 Blockade [Phase 2]
A phase 2 trial evaluating chidamide plus camrelizumab as second-line therapy for advanced esophageal squamous cell carcinoma after prior PD…
-
CLINICAL_TRIALS trial_result · 2021-07-13Clinical Trial Update: Afatinib Plus Toripalimab in Previously Treated ESCC With EGFR Overexpression or EGFR Amplification [Phase 2]
Phase 2 trial update exploring afatinib plus toripalimab in previously treated esophageal squamous cell carcinoma with EGFR overexpression o…
-
CLINICAL_TRIALS trial_result · 2021-07-07Clinical Trial Update: Concurrent Chemoradiotherapy After Endoscopic Resection for Stage I Esophageal Carcinoma [Phase 2]
Phase 2 trial investigating concurrent chemoradiotherapy after endoscopic resection for stage I esophageal carcinoma (esophageal squamous ce…